万征,杜鑫

• 1:天津医科大学总医院心血管病中心

摘要(Abstract)：

<正>心房颤动(房颤)是临床最常见的心律失常之一,不仅降低了患者的生活质量,还可导致卒中或心力衰竭甚至死亡等严重后果。随着对房颤发生机制的不断认识,房颤的治疗取得了新的突破,各种导管消融的术式或策略相继应用于临床,疗效不断得以改善,安全性也得到证实,适应证随之不断扩展和更新。然而,房颤导管消融的疗效和方法学还有不尽如人意之处。就阵发性房颤而言,其导管消融治疗的成功率仍在70%左右徘徊,1年后的复发率高达30%,持续性和慢性房颤导管消融的成功率和复发率更高[1]。

关键词(KeyWords)： 心房纤维化;心房颤动;心脏磁共振;导管消融

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 万征,杜鑫

参考文献(References)：

• [1]Calkins H,Kuck KH,Cappato R,et al.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design.Heart Rhythm,2012,9:632-696.
• [2]Higuchi K,Akkaya M,Akoum N,et al.Cardiac MRI assessment of atrial fibrosis in atrial fi brillation:implications for diagnosis and therapy.Heart,2014,100:590-596.
• [3]Velagapudi P,Turagam M,Leal MA,et al.Atrial fibrosis:a risk stratifier for atrial fibrillation.Expert Rev Cardiovasc Ther,2013,11:155-160.
• [4]徐晤,王志荣,李思召,等.快速心房起搏引起猪心房颤动时心房结构的变化及替米沙坦的预防作用.中国介入心脏病学杂志,2012,20:338-342.
• [5]Burstein B,Nattel S.Atrial Fibrosis:Mechanisms and Clinical Relevance in Atrial Fibrillation.J Am Coll Cardiol,2008,51:802-809.
• [6]Wang GD,Shen LH,Wang L,et al.Relationship between integrated backscatter and atrial fibrosis in patients with and without atrial fibrillation who are undergoing coronary bypass surgery.Clin Cardiol,2009,32:E56-E61.
• [7]Seitz J,Horvilleur J,Lacotte J,at al.Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance.Pacing Clin Electrophysiol,2011,34:1267-77.
• [8]Vergara GR,Marrouche NF.Tailored management of atrial fibrillation using a LGE-MRI based model:from the clinic to the electrophysiology laboratory.J Cardiovasc Electrophysiol,2011,22:481-487.
• [9]Oakes RS,Badger TJ,Kholmovski EG,et al.Detection and quantification of left atrial structural remodeling with delayedenhancement magnetic resonance imaging in patients with atrial fi brillation.Circulation,2009,119:1758-1767.
• [10]Akoum N,Daccarett M,Mcgann C,et al.Atrial fibrosis helps seselect the appropriate patient and strategy in catheter ablation of atrial fibrillation:a DE-M R I guided approach.J Cardiovasc Electrophysiol,2011,22:16-22.
• [11]Kellman P,Arai AE.Cardiac imaging techniques for physicians:late enhancement.Journal J Magn Reson Imaging,2012,36:529-542.
• [12]McGann C,Akoum N,Patel A,et al.Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI.Circ Arrhythm Electrophysio,2014,7:23-30.
• [13]Marrouche NF,Wilber D,Hindricks G,et al.Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study.JAMA,2014,311:498-506.
• [14]Akoum N,Fernandez G,Wilson B,et al.Association of Atrial Fibrosis Quantified Using LGE-MRI with Atrial Appendage Thrombus and Spontaneous Contrast on Transesophageal Echocardiography in Patients with Atrial Fibrillation.J Cardiovasc Electrophysiol,2013,24:1104-1109.